Screener
Solid Biosciences Inc. SLDB Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s net income?
- Solid Biosciences Inc. (SLDB) reported net income of -$54.8M in Q2 2026.
- How has Solid Biosciences Inc.'s net income changed year-over-year?
- Solid Biosciences Inc.'s net income decreased by 38.8% year-over-year, from -$39.48M to -$54.8M.
- What is the long-term trend for Solid Biosciences Inc.'s net income?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s net income has grown at a 24.7% compound annual growth rate (CAGR), from -$72.19M to -$174.33M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Solid Biosciences Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude